Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Pascal Van Bleyenbergh"'
Autor:
Emmanuel André, Natalie Lorent, Kurt Beuselinck, Susanne Deiwick, Lieven Dupont, Johanne Gafsi, Lies Laenen, Lise Raymaekers, Pascal Van Bleyenbergh, John D. Perry, Barbara C. Kahl
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT The performance of a novel selective agar was evaluated against the performance of conventional mycobacterial cultures, i.e., a combination of the mycobacterial growth indicator tube (MGIT) with Löwenstein-Jensen (LJ), for the detection of
Externí odkaz:
https://doaj.org/article/fe2a23512554499d95205a4e00089888
Autor:
Saartje Demolder, Veronique Schaevers, Katrien Lagrou, Paul De Munter, Hanne Beeckmans, Geert M. Verleden, Laurent Godinas, Lieven J. Dupont, Pascal Van Bleyenbergh, Natalie Lorent, Robin Vos
Publikováno v:
Transplant International, Vol 37 (2024)
Lung transplant (LTx) recipients are at high risk for COVID-19 related morbidity and mortality. Data regarding pre-exposure prophylaxis (PrEP) with tixagevimab-cilgavimab in this population are scarce. We therefore evaluated COVID-19 breakthrough inf
Externí odkaz:
https://doaj.org/article/f71bae62342141ceb7df5b8eb5eab929
Autor:
Marie Yskout, Joke Vliebergh, Hakan Bor, Lieven Dupont, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
Publikováno v:
Case Reports in Endocrinology, Vol 2023 (2023)
Introduction. Cystic fibrosis transmembrane regulator (CFTR) modulator therapies improve respiratory function and glycaemic control in patients with cystic fibrosis (CF). The direct effect of CFTR modulator therapies on pancreatic function in patient
Externí odkaz:
https://doaj.org/article/fa1130b3364941fda98ae0a1c3647775
Autor:
Natalie Lorent, Yannick Vande Weygaerde, Eveline Claeys, Ipek Guler Caamano Fajardo, Nicolas De Vos, Walter De Wever, Bihiyga Salhi, Iwein Gyselinck, Cedric Bosteels, Bart N. Lambrecht, Stephanie Everaerts, Sven Verschraegen, Christophe Schepers, Heleen Demeyer, Arne Heyns, Pieter Depuydt, Sandra Oeyen, Pascal Van Bleyenbergh, Laurent Godinas, Lieven Dupont, Greet Hermans, Eric Derom, Rik Gosselink, Wim Janssens, Eva Van Braeckel
Publikováno v:
ERJ Open Research, Vol 8, Iss 2 (2022)
Background Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are needed to understand their recovery trajectory and additional care needs. Methods A prospective observational multicentre cohort study was carried out of adults ho
Externí odkaz:
https://doaj.org/article/41bb34eef7fd44abbc7a0f11e5068611
Publikováno v:
ERJ Open Research, Vol 4, Iss 1 (2018)
There is growing awareness of the need for advance care planning in patients with chronic obstructive pulmonary disease (COPD). However, do-not-resuscitate (DNR) order implementation remains a challenge in clinical practice. We retrospectively analys
Externí odkaz:
https://doaj.org/article/4a4105a816b04110bd7670a8233591e5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marie Yskout, Vliebergh Joke, Schueren Bart Van der, Dupont Lieven, Lorent Natalie, Mertens Ann, Gillard Pieter, Pascal Van Bleyenbergh, Bor Hakan, Vangoitsenhoven Roman, Mathieu Chantal
Publikováno v:
Endocrine Abstracts.
Autor:
Laurent Godinas, Dirk Van Raemdonck, Sofie Happaerts, Bart M. Vanaudenaerde, Christophe Dooms, Pascal Van Bleyenbergh, Jonas Yserbyt, Laurens J. Ceulemans, Geert Verleden, Robin Vos, Natalie Lorent, Lieven Dupont, Stijn E. Verleden
Publikováno v:
Transplantation.
Introduction: COVID-19 raises concerns for lung transplant recipients (LTX) due to the lung as a target organ in immunocompromised patients. Aims and objectives: Evaluating COVID-19 course, treatments received, radiological and functional evolution i
Autor:
Yves Debaveye, Pascal Van Bleyenbergh, Omar Elkayal, Erwin Dreesen, Robin Vos, Henk-Jan Guchelaar, Ruth Van Daele, Katrien Lagrou, Pieter Vermeersch, Roger J. M. Brüggemann, Isabel Spriet
Publikováno v:
Mycoses, 64, 9, pp. 1111-1116
Mycoses. WILEY
Mycoses
Mycoses, 64, 1111-1116
Mycoses. WILEY
Mycoses
Mycoses, 64, 1111-1116
Item does not contain fulltext BACKGROUND: Isavuconazole is a triazole antifungal drug, approved for the treatment of invasive aspergillosis and mucormycosis. Isavuconazole is metabolised by CYP3A4 and CYP3A5, and it has been shown that the CYP3A ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ef024bf67903ef3e7fd352baba6b2f
https://repository.ubn.ru.nl/handle/2066/238514
https://repository.ubn.ru.nl/handle/2066/238514
Autor:
N Lorent, Yannick Vande Weygaerde, Eveline Claeys, Nicolas De Vos, W De Wever, Bihiyga Salhi, Iwein Gyselinck, Cedric Bosteels, Stephanie Everaerts, Sven Verschraegen, Christophe Schepers, Heleen Demeyer, Arne Heyns, Pieter Depuydt, Sandra Oeyen, Pascal Van Bleyenbergh, Laurent Godinas, Lieven Dupont, G Hermans, Eric Derom, Rik Gosselink, Wim Janssens, Eva Van Braeckel
Publikováno v:
SSRN Electronic Journal.